Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40002514
Localisation
Italy
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
24/10/2024
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2035
Overall Net-Zero Target: Chiesi Farmaceutici S.p.A commits to reach net-zero greenhouse gas emissions across the value chain by 2035. Near-Term Targets: Chiesi Farmaceutici S.p.A commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2030 from a 2019 base year.* Chiesi Farmaceutici S.p.A commits to reduce scope 3 GHG emissions from use of sold products 80% per unit of respiratory product sold by 2030 from a 2019 base year.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Chiesi Farmaceutici S.p.A commits to maintain a minimum of 90% absolute scope 1 and 2 GHG emissions from 2030 through 2035 from a 2019 base year. Chiesi Farmaceutici S.p.A commits to reduce absolute Scope 3 GHG emissions from purchased goods and services, business travel and use of sold products 90% by 2035 from a 2019 base year. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
2035
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
8156009817CA59AD8106
Source : Science Based Targets initiative | Données publiques